Michael G Schrauder

Summary

Affiliation: University of Erlangen-Nuremberg
Country: Germany

Publications

  1. pmc Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection
    Michael G Schrauder
    Department of Obstetrics and Gynaecology, University Hospital Erlangen, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    PLoS ONE 7:e29770. 2012
  2. doi request reprint Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer
    M Schrauder
    University Breast Center for Franconia, Erlangen University Hospital, Universitaetsstrasse 21 23, 91054, Erlangen, Bavaria, Germany
    J Cancer Res Clin Oncol 134:873-82. 2008
  3. doi request reprint Diabetes and prognosis in a breast cancer cohort
    Michael G Schrauder
    Department of Obstetrics and Gynaecology, University Hospital Erlangen, Erlangen, Germany
    J Cancer Res Clin Oncol 137:975-83. 2011
  4. doi request reprint Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors
    Michael P Lux
    University Breast Center Franconia, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen EMN, University Hospital Erlangen, Friedrich Alexander University of Erlangen Nuremberg, Universitätsstrasse 21 23, 91054, Erlangen, Germany
    Breast Cancer Res Treat 139:429-40. 2013
  5. ncbi request reprint Health utilities in gynecological oncology and mastology in Germany
    Thomas Hildebrandt
    Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitätsstrasse 21 23, 91054 Erlangen, Germany
    Anticancer Res 34:829-35. 2014
  6. pmc Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients
    Alexander Hein
    Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen Nuremberg, Comprehensive Cancer Center Erlangen EMN, Erlangen, Germany
    Biomed Res Int 2014:842452. 2014
  7. doi request reprint Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
    Christian R Loehberg
    Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen Nuremberg, Universitätsstrasse 21 23, 91054 Erlangen, Bavaria, Germany
    Breast Cancer Res Treat 138:899-908. 2013
  8. doi request reprint Hormone replacement therapy and prognosis in ovarian cancer patients
    Alexander Hein
    Department of Gynecology and Obstetrics, Comprehensive Cancer Center, Erlangen University Hospital, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Eur J Cancer Prev 22:52-8. 2013
  9. doi request reprint Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients
    David L Wachter
    Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Arch Gynecol Obstet 287:337-44. 2013
  10. doi request reprint Financing of certified centers: a willingness-to-pay analysis
    Falk C Thiel
    Department of Gynecology, Erlangen University Hospital, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Arch Gynecol Obstet 287:495-509. 2013

Collaborators

Detail Information

Publications15

  1. pmc Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection
    Michael G Schrauder
    Department of Obstetrics and Gynaecology, University Hospital Erlangen, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
    PLoS ONE 7:e29770. 2012
    ..We investigated whether microarray-based miRNA profiling on whole blood could discriminate between early stage breast cancer patients and healthy controls...
  2. doi request reprint Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer
    M Schrauder
    University Breast Center for Franconia, Erlangen University Hospital, Universitaetsstrasse 21 23, 91054, Erlangen, Bavaria, Germany
    J Cancer Res Clin Oncol 134:873-82. 2008
    ..Recent studies have produced contradictory results regarding the association between ATM genetic variants and breast cancer risk...
  3. doi request reprint Diabetes and prognosis in a breast cancer cohort
    Michael G Schrauder
    Department of Obstetrics and Gynaecology, University Hospital Erlangen, Erlangen, Germany
    J Cancer Res Clin Oncol 137:975-83. 2011
    ..The aim of this retrospective cohort study was to examine the effect of diabetes on the clinical course and the prognosis of early stage breast cancer in relation to tumour and patient characteristics...
  4. doi request reprint Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors
    Michael P Lux
    University Breast Center Franconia, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen EMN, University Hospital Erlangen, Friedrich Alexander University of Erlangen Nuremberg, Universitätsstrasse 21 23, 91054, Erlangen, Germany
    Breast Cancer Res Treat 139:429-40. 2013
    ..There appear to be some indicators that might help address the problem, such as the physicians' level of training and experience and the patients' specific social circumstances...
  5. ncbi request reprint Health utilities in gynecological oncology and mastology in Germany
    Thomas Hildebrandt
    Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitätsstrasse 21 23, 91054 Erlangen, Germany
    Anticancer Res 34:829-35. 2014
    ..However, these may widely deviate from the values for a woman actually living in Germany. It is, therefore, necessary to collect and analyze health utilities in Germany...
  6. pmc Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients
    Alexander Hein
    Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen Nuremberg, Comprehensive Cancer Center Erlangen EMN, Erlangen, Germany
    Biomed Res Int 2014:842452. 2014
    ..The effect of rs1054016(RANKL) adds to the evidence that the RANK pathway plays a role in BC pathogenesis and progression with respect to BMFS, emphasizing the connection between BC and bone health. ..
  7. doi request reprint Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
    Christian R Loehberg
    Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen Nuremberg, Universitätsstrasse 21 23, 91054 Erlangen, Bavaria, Germany
    Breast Cancer Res Treat 138:899-908. 2013
    ..Ki-67 is useful in addition to known prognostic factors for breast cancer. It is able to indicate a group of women with a poorer prognosis, specifically in the group of patients with PR-positive breast cancer...
  8. doi request reprint Hormone replacement therapy and prognosis in ovarian cancer patients
    Alexander Hein
    Department of Gynecology and Obstetrics, Comprehensive Cancer Center, Erlangen University Hospital, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Eur J Cancer Prev 22:52-8. 2013
    ..Sex hormone exposure through HRT may influence the behavior of ovarian cancers after the onset of the disease. This study supports the hypothesis that ovarian cancer is a hormonally influenced tumor...
  9. doi request reprint Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients
    David L Wachter
    Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Arch Gynecol Obstet 287:337-44. 2013
    ..This study analyzed the value of immunohistochemical biomarkers for predicting pathological complete response (pCR) and prognosis in a group of BC patients receiving standardized treatment...
  10. doi request reprint Financing of certified centers: a willingness-to-pay analysis
    Falk C Thiel
    Department of Gynecology, Erlangen University Hospital, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Arch Gynecol Obstet 287:495-509. 2013
    ..A hypothetical maximum willingness to pay can be calculated using a willingness-to-pay analysis, making it possible to identify deficiencies in the arbitrary setting of health budgets at the macro-level...
  11. doi request reprint Assessment of mammographic density before and after first full-term pregnancy
    Christian R Loehberg
    Department of Obstetrics and Gynecology, University Breast Center Franconia, Erlangen, Germany
    Eur J Cancer Prev 19:405-12. 2010
    ..It may be hypothesized that breast cancer risk reduction associated with pregnancy is mediated through a direct reduction of MD, and MD assessment might be incorporated in individualizing risk assessment and prevention...
  12. ncbi request reprint Comprehensive visualization of paresthesia in breast cancer survivors
    Sebastian M Jud
    Department of Gynecology and Obstetrics, University Breast Center for Franconia, Erlangen University Hospital, Universitaetsstrasse 21 23, 91054, Erlangen, Germany
    Arch Gynecol Obstet 290:135-41. 2014
    ..This article presents a new method of assessing the spatial distribution of paresthesia in breast cancer survivors after different locoregional treatments...
  13. doi request reprint Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians
    Falk C Thiel
    University Breast Center for Franconia, Department of Gynaecology and Obstetrics, Friedrich Alexander University of Erlangen Nuremberg, Universitätsstrasse 21 23, Erlangen Nuremberg 91054, Germany
    Breast Cancer Res Treat 135:811-20. 2012
    ..Individual factors were also identified in both groups that significantly influence thresholds for accepting adjuvant treatment, independently of risk estimates and therapy guidelines...
  14. doi request reprint The era of centers: the influence of establishing specialized centers on patients' choice of hospital
    Michael Patrick Lux
    University Breast Center of Franconia UBF, Department of Gynecology, Erlangen University Hospital, Universitätstrasse 21 23, 91054 Erlangen, Germany
    Arch Gynecol Obstet 283:559-68. 2011
    ..It is considered that establishing accredited specialized centers can serve as a marketing tool. This study investigated whether accredited specialized centers influence patients' choice of hospital...
  15. doi request reprint Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001
    Christian R Loehberg
    Department of Obstetrics and Gynecology, University Hospital Erlangen, Universitaetsstr 21 23, 91054 Erlangen, Germany
    Biochem Pharmacol 83:480-8. 2012
    ....